GEMS serves to provide a comprehensive assessment of HIV drug resistance risk during PrEP use and policy recommendations for the frequency of HIV testing and resistance monitoring for projects implementing PrEP in sub-Saharan Africa.
For further information about GEMS, click here for our project factsheet.